27507-15-9

Basic information

• Product Name: 3-Aminopyridine-2-carboxylic acid ethyl ester
• Synonyms: 3-Aminopyridine-2-carboxylic acid ethyl ester;3-Aminopicolinic acid ethyl ester;Ethyl 3-Aminopyridine-2-carboxylate;2-Pyridinecarboxylic acid, 3-aMino-, ethyl ester;3-AMino-2-pyridinecarboxylic Acid Ethyl Ester;Ethyl 3-AMinopicolinate;Picolinic acid, 3-amino-, ethyl ester
• CAS NO: 27507-15-9
• Molecular Formula: C₈H₁₀N₂O₂
• Molecular Weight: 166.1772
• Product Categories: pharmacetical;API intermediates;Amines;Aromatics;Heterocycles;Intermediates
• Mol File: 27507-15-9.mol

Chemical Properties

• Melting Point: 131-133 °C
• Boiling Point: 326.2°Cat760mmHg
• Flash Point: 151.1°C
• Appearance: /
• Density: 1.192g/cm³
• Vapor Pressure: 0.000219mmHg at 25°C
• Refractive Index: 1.558
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.79±0.10(Predicted)
• CAS DataBase Reference: 3-Aminopyridine-2-carboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Aminopyridine-2-carboxylic acid ethyl ester(27507-15-9)
• EPA Substance Registry System: 3-Aminopyridine-2-carboxylic acid ethyl ester(27507-15-9)

Safety Data

• Hazardous Substances Data: 27507-15-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3-Aminopyridine-2-carboxylic acid ethyl ester is used as a synthetic intermediate for the development of Kenpaullone derivatives, which are known for their potential applications in the treatment of various diseases, including cancer.
Used in Pharmaceutical Industry (continued):
3-Aminopyridine-2-carboxylic acid ethyl ester is also used as a synthetic intermediate for the synthesis of Cannabinoid receptor ligands. These ligands have potential therapeutic applications in the treatment of various conditions, such as pain, inflammation, and neurological disorders.
Used in Pharmaceutical Industry (continued):
Furthermore, 3-Aminopyridine-2-carboxylic acid ethyl ester is utilized as a synthetic intermediate for the development of nociceptive agents. These agents are designed to modulate the perception of pain and could be used in the treatment of chronic pain conditions.

InChI:InChI=1/C8H10N2O2/c1-2-12-8(11)7-6(9)4-3-5-10-7/h3-5H,2,9H2,1H3

Upstream product

• 64-17-5 ethanol 
• 1462-86-8 3-amino-pyridine-2-carboxylic acid 
• 462-08-8 pyridin-3-ylamine 
• 617-35-6 2-oxo-propionic acid ethyl ester 

Downstream Products

• 857433-55-7 3-[(N-acetyl-sulfanilyl)-amino]-pyridine-2-carboxylic acid ethyl ester 
• 3303-28-4 3-Amino-picolinsaeure-hydrazid 
• 98140-94-4 3-amino-2-picolinehydroxamic acid 
• 24541-52-4 3-phenyl-2,4-dioxo-1,2,3,4-tetrahydropyrido<3,2-d>pyrimidine 
• 60058-16-4 1,5-naphthyridine-2,4-diol 
• 153687-07-1 3-[2-(2-Methoxy-phenyl)-acetylamino]-pyridine-2-carboxylic acid ethyl ester 
• 52378-63-9 3-amino-2-hydroxy-methylpyridine 
• 110440-77-2 N,N'-bis-(2-ethoxycarbonyl-[3]pyridyl)-malonamide 
• 676596-63-7 5H-pyrido[3,2-b]azepine-6,9(7H,8H)-dione 
• 676596-62-6 9-hydroxy-6-oxo-6,7-dihydro-5H-pyrido[3,2-b]azepine-8-carboxylic acid ethyl ester 
• 676596-64-8 9-[(4-bromo-phenyl)-hydrazono]-5,7,8,9-tetrahydro-pyrido[3,2-b]azepin-6-one 
• 153687-08-2 4-hydroxy-3-(o-methoxyphenyl)-1,5-naphthyridin-2(1H)-one 
• 153687-10-6 2,4-dichloro-3-(o-methoxyphenyl)-1,5-naphthyridine 
• 128037-06-9 2-ethoxy-3-hydroxypyrido<3,2-d>pyrimidin-4(3H)-one 

Relevant articles and documents

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR6 or N; Y is CR3 or N; R1, R2, R3, R4, R5, R6, R7, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

SUBSTITUTED NAPHTHYRIDINONE COMPOUNDS USEFUL AS T CELL ACTIVATORS

Disclosed are compounds of Formula (I) or a salt thereof, wherein: R1, R2, R3, R4, R5, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

PDE9 inhibitor and uses thereof

The invention belongs to the technical field of medicines, particularly relates to a PDE9 inhibitor compound shown as a formula (I) or pharmaceutically acceptable salt, isomer, a deuterated compound,metabolite and prodrug thereof, and further relates to pharmaceutical preparations, pharmaceutical compositions and application of the compounds. X1, X2, X3, X4, R1, R2, ring A, L and m are defined inthe specification. The compounds can be used for preparing medicines for treating or preventing related diseases mediated by PDE9.

PYRIMIDINE AND TRIAZINE DERIVATIVES AND THEIR USE AS AXL INHIBITORS

Compounds of the general formula(I): (I) processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

MACROCYCLIC KINASE INHIBITORS

Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.

SUBSTITUTED ARYL PYRIMIDINONE DERIVATIVES

Substituted aryl pyrimidinone derivatives are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.

9-Cyano-1-azapaullone (Cazpaullone), a Glycogen Synthase Kinase-3 (GSK-3) inhibitor activating pancreatic β cell protection and replication

Recently, the serine/threonine kinase glycogen synthase kinase-3 (GSK-3) emerged as a regulator of pancreatic β cell growth and survival. On the basis of the previous observation that GSK-3 inhibitors like 1-azakenpaullone promote β cell protection and re

2-PHENOXY PYRIMIDINONE ANALOGUES

2-Phenoxy pyrimidinone analogues are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment

HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES

Haloalkyl-substituted pyrimidinone derivatives are provided, of the Formula (I): wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful

CIS-CYCLOHEXYL SUBSTITUTED PYRIMIDINONE DERIVATIVES

Cis-cyclohexyl substituted pyrimidinone derivatives are provided, of Formula (I) wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful